Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

CALAVI, 2020 NCT04346199

acalabrutinib (n=70) vs. standard of care (n=70)

randomized controlled trial   risk of bias NA

Studied treatment

acalabrutinib

Control treatment

standard of care

Patients

COVID 19 hospitalized

Method

open label

1 center, Argentina

Remark

CALAVI US, 2020 NCT04380688

acalabrutinib (n=31) vs. standard of care (n=31)

randomized controlled trial   risk of bias NA

Studied treatment

acalabrutinib

Control treatment

standard of care

Patients

COVID 19 hospitalized

Method

open label

multicenters, USA

Remark